Carolinas Wealth Consulting LLC Myriad Genetics Inc Transaction History

Carolinas Wealth Consulting LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$14.51 - $20.99 $72 - $104	-5 Reduced 4.17%	115 $1,000
Q4 2021 Feb 14, 2022	BUY	$24.13 - $32.63 $24 - $32	1 Added 0.84%	120 $3,000
Q2 2021 Aug 17, 2021	SELL	$25.39 - $32.61 $888 - $1,141	-35 Reduced 22.73%	119 $4,000
Q1 2021 May 17, 2021	BUY	$19.92 - $31.6 $856 - $1,358	43 Added 38.74%	154 $5,000
Q4 2020 Feb 16, 2021	SELL	$12.16 - $19.77 $243 - $395	-20 Reduced 15.27%	111 $2,000
Q3 2020 Nov 12, 2020	BUY	$11.25 - $14.75 $1,473 - $1,932	131 New	131 $2,000

228

92M

297K

20.7K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $821M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Carolinas Wealth Consulting LLC, based on Form 13F filings with the SEC.

Stay updated on Carolinas Wealth Consulting LLC with notifications on news.